{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:15:01Z","timestamp":1783142101185,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2308085MH310"],"award-info":[{"award-number":["2308085MH310"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024YFFK0008"],"award-info":[{"award-number":["2024YFFK0008"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejmech.2026.118892","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:04:10Z","timestamp":1777305850000},"page":"118892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rational design, synthesis, and evaluations of HBV capsid assembly modulators featuring a core of 2-amino-5-(2-amino-2-oxoacetyl)-4-methylthiophene-3-carboxamide"],"prefix":"10.1016","volume":"313","author":[{"given":"Xinglong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-1768","authenticated-orcid":false,"given":"Chenzhong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejmech.2026.118892_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12072-018-9884-8","article-title":"Global HBV burden: guesstimates and facts","volume":"12","author":"Ginzberg","year":"2018","journal-title":"Hepatol. Int."},{"issue":"18","key":"10.1016\/j.ejmech.2026.118892_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16183307","article-title":"A global view to HBV chronic infection: evolving strategies for diagnosis, treatment and prevention in immunocompetent individuals","volume":"16","author":"Nicolini","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"40","key":"10.1016\/j.ejmech.2026.118892_bib3","doi-asserted-by":"crossref","first-page":"14598","DOI":"10.3748\/wjg.v20.i40.14598","article-title":"Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review","volume":"20","author":"Sun","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118892_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bpg.2017.04.012","article-title":"Current treatment guidelines of chronic hepatitis B: the role of nucleos(t)ide analogues and peginterferon","volume":"31","author":"Ghany","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.ejmech.2026.118892_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112714","article-title":"Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies","volume":"206","author":"Ren","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118892_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117093","article-title":"Recent advances in screening methods enabling the discovery of novel anti-hepatitis B virus drug candidates","volume":"282","author":"Jin","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118892_bib8","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1021\/acs.jmedchem.4c02838","article-title":"Discovery of AIC263282, a hepatitis B virus capsid assembly modulator ready for candidate profiling","volume":"68","author":"Lesch","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118892_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117441","article-title":"Design and biochemical evaluation of 2-cyclopropyl-thioureidobenzamide (CP-TBA) derivatives as potent HBV capsid assembly modulators targeting a novel binding site","volume":"289","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118892_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/ciaa961","article-title":"Antiviral activity and pharmacokinetics of the Hepatitis B Virus (HBV) capsid assembly modulator GLS4 in patients with chronic HBV infection","volume":"73","author":"Zhang","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118892_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.bmc.2016.12.017","article-title":"Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4)","volume":"25","author":"Ren","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2026.118892_bib12","doi-asserted-by":"crossref","first-page":"10352","DOI":"10.1021\/acs.jmedchem.9b01421","article-title":"A new approach of mitigating CYP3A4 induction led to the discovery of potent Hepatitis B Virus (HBV) capsid inhibitor with optimal ADMET profiles","volume":"62","author":"Lin","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118892_bib13","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1021\/acs.jmedchem.3c00173","article-title":"Discovery of Linvencorvir (RG7907), a hepatitis B virus core protein allosteric modulator, for the treatment of chronic HBV infection","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118892_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01734-18","article-title":"Preclinical characterization of NVR 3-778, a first-in-class capsid assembly modulator against Hepatitis B virus","volume":"63","author":"Lam","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118892_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103363","article-title":"Design, synthesis and anti-HBV activity of NVR3-778 derivatives","volume":"94","author":"Lv","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118892_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129456","article-title":"Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506","volume":"94","author":"Cole","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118892_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01463-20","article-title":"Preclinical profile and characterization of the Hepatitis B virus core protein inhibitor ABI-H0731","volume":"64","author":"Huang","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118892_bib18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2022.05.027","article-title":"Safety and efficacy of vebicorvir administered with entecavir in treatment-na\u00efve patients with chronic hepatitis B virus infection","volume":"77","author":"Sulkowski","year":"2022","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118892_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2020.04.036","article-title":"JNJ-56136379, an HBV capsid assembly modulator, is well-tolerated and has antiviral activity in a phase 1 Study of patients with chronic infection","volume":"159","author":"Zoulim","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118892_bib20","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/jac\/dkaa179","article-title":"Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro","volume":"75","author":"Verbinnen","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"18","key":"10.1016\/j.ejmech.2026.118892_bib21","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1021\/acs.jmedchem.4c01568","article-title":"Rational design, synthesis, and structure-activity relationship of a novel isoquinolinone-based series of HBV capsid assembly modulators leading to the identification of clinical candidate AB-836","volume":"67","author":"Cole","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118892_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106010","article-title":"Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virus","volume":"231","author":"Lam","year":"2024","journal-title":"Antiviral Res"},{"issue":"23","key":"10.1016\/j.ejmech.2026.118892_bib23","doi-asserted-by":"crossref","first-page":"21126","DOI":"10.1021\/acs.jmedchem.4c01814","article-title":"The discovery and preclinical profile of ALG-000184, a prodrug of the potent Hepatitis B virus capsid assembly modulator ALG-001075","volume":"67","author":"Vendeville","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118892_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(25)00293-6","article-title":"ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trial","author":"Yuen","year":"2026","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118892_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1039\/D1MD00318F","article-title":"The identification of highly efficacious functionalised tetrahydrocyclopenta[c]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assembly","volume":"13","author":"Cole","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118892_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115952","article-title":"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents","volume":"31","author":"Amblard","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118892_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2018.12.047","article-title":"5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors","volume":"164","author":"Tang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118892_bib28","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1021\/acs.jmedchem.2c00335","article-title":"Mechanistic insights for drug repurposing and the design of hybrid drugs for Alzheimer's Disease","volume":"65","author":"Padhi","year":"2022","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2026.118892_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127514","article-title":"Structural hybridization as a facile approach to new drug candidates","volume":"30","author":"Sampath Kumar","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118892_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01701-19","article-title":"Novel hepatitis B virus capsid assembly modulator induces potent antiviral responses in vitro and in humanized mice","volume":"64","author":"Amblard","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118892_bib31","article-title":"A Recent prevalence of Hepatitis B Virus (HBV) genotypes and subtypes in Asia: a systematic review and meta-analysis","volume":"11","author":"Bello","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118892_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106446","article-title":"Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: a multicenter clinical trial","volume":"90","author":"Zhang","year":"2025","journal-title":"J. Infect."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118892_bib33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:15:07Z","timestamp":1783138507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426003375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S0223523426003375"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118892","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design, synthesis, and evaluations of HBV capsid assembly modulators featuring a core of 2-amino-5-(2-amino-2-oxoacetyl)-4-methylthiophene-3-carboxamide","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118892"}}